loading page

Reinforcing MgO nanoparticles with 3D printed sodium alginate/silk fibroin/polyvinyl alcohol/nano-hydroxyapatite composite structure enhanced biomimetic potential for defect bone tissue repair.
  • Partha Sarathi Majhi,
  • Krishna Pramanik
Partha Sarathi Majhi
National Institute of Technology Rourkela Department of Biotechnology and Medical Engineering
Author Profile
Krishna Pramanik
National Institute of Technology Rourkela Department of Biotechnology and Medical Engineering

Corresponding Author:mondalkp@gmail.com

Author Profile

Abstract

The current research investigates the effect of reinforcing magnesium oxide nanoparticles (n-MgO) on the physico-chemical, mechanical, and cellular activities of our previously developed three-dimensional printed sodium alginate (SA)/silk fibroin (SF)/polyvinyl alcohol (PVA)/nano-hydroxyapatite (HA) composite scaffold with optimized composition containing SA/SF:70:30 (v/v) with 3wt% PVA tri-polymer ratio and 1.5wt% n-HA designated as SA 70/SF 30/PVA 3/n-HA 1.5 proven to be a suitable matrix for bone tissue engineering application. The chemically synthesized n-MgO was incorporated at two different concentrations of 0.5 wt% and 1 wt% into the SA/SF/PVA/n-HA solution and the resulting composite bioinks were used to fabricate 3D printed scaffolds as SA 70/SF 30/PVA 3/n-HA 1.5/n-MgO 0.5 and SA 70/SF 30/PVA 3/n-HA 1.5/n-MgO 1. The scaffolds possess a microfibrous interconnected porous network with desired pore sizes ranging from 384±74µm and 362±57µm. The tensile strength measuring 4.09±1.13 MPa and 5.08±1.14 MPa for SA 70/SF 30/PVA 3/n-HA 1.5/n-MgO 0.5 and SA 70/SF 30/PVA 3/n-HA 1.5/n-MgO 1 was enhanced upon reinforcing n-MgO matching with the mechanical strength of a cancellous bone and suitable for bone tissue regeneration under the load condition. In-vitro cell studies performed with HOS cells have shown the cytocompatible properties of the SA 70/SF 30/PVA 3/n-HA 1.5/n-MgO 1 scaffold. The up-regulation of ALP activity indicated that the scaffold might support superior osteoblast function and differentiation.
18 Jan 2025Submitted to Biotechnology and Bioengineering
20 Jan 2025Submission Checks Completed
20 Jan 2025Assigned to Editor
20 Jan 2025Review(s) Completed, Editorial Evaluation Pending
28 Jan 2025Reviewer(s) Assigned